Patients' outcome according to <i>BRAF</i> mutations status.
- Zacharenia Saridaki (357374)
- Maria Tzardi (357376)
- Chara Papadaki (269416)
- Maria Sfakianaki (357378)
- Fraga Pega (357380)
- Aristea Kalikaki (357382)
- Eleftheria Tsakalaki (357383)
- Maria Trypaki (269427)
- Ippokratis Messaritakis (357384)
- Efstathios Stathopoulos (357386)
- Dimitris Mavroudis (74460)
- Vassilis Georgoulias (74459)
- John Souglakos (74461)
Publication date
February 2013
DOIAbstract
<p>Panel A: Time to Tumor Progression (TTP) in the whole patients' population. Panel B: Median Overall Survival (OS) in the whole patients' population Panel C: Time to Tumor Progression (TTP) in patients with <i>KRAS</i> wt primary tumors. Panel D: Median Overall Survival (OS) in patients with <i>KRAS</i> wt primary tumors.</p
Add to ORKG